Protein Structure Could Lead to Better Treatments for HIV, Early Aging
APRIL 9, 2013
Researchers have determined the molecular structure of a protein whose mutations have been linked to several early aging diseases, and side effects for common human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) medications. This breakthrough could eventually help researchers develop new treatments for these early-aging diseases and redesign AIDS medications to avoid side effects such as diabetes. The research was carried out at the Southeastern Regional Collaborative Access Team (SER-CAT) facility at the U.S. Department of Energy Office of Science’s Advanced Photon Source (APS) at Argonne National Laboratory.
The researchers from the University of Virginia School of Medicine, the Hauptman-Woodward Medical Research Institute, and the University of Rochester School of Medicine and Dentistry determined the molecular structure of the enzyme Ste24p. Their Membrane Protein Structural Biology Consortium is funded by the National Institutes of Health Protein Structure Initiative, which supports the determination of molecular structures of biomedically important target proteins. Their findings were published March 29 in the journal Science.
The nucleus of a cell is lined with a mesh-like structure called lamin that serves as a scaffold for maintaining nuclear shape and function. Lamin requires the action of another protein, called Ste24p protease, which removes specific parts of the lamin filament and enables proper assembly of the mesh. The research team determined the structure of a Ste24p protein found in a close relative of baker’s yeast, whose properties are interchangeable with the same protein found in humans.
These experiments required to solve the structure of Ste24p were performed remotely at the Southeastern Regional Collaborative Access Team x-ray beamline 24-ID at the APS. Working from Charlottesville, UVA researchers can log onto a computer program to remotely control the robots sample-handlers at the SER-CAT facility to perform research and to collect data.
In humans, improper processing and assembly of lamin lead to a group of diseases known as laminopathies, which include muscular dystrophy, cardiomyopathies, and a collection of rare accelerated aging diseases in children called progerias. The research team focused on Ste24p because defects in this protein in humans are responsible for a number of progerias.
In addition, some frequently used HIV and AIDS medications utilized in highly active antiretroviral therapy (HAART) also interact with Ste24p, which may lead to alterations in the way patients taking the drugs metabolize fat and may lead to treatment side effects that can include insulin resistance and diabetes, Pryor said.
Knowing how the protein is structured could aid researchers in developing drugs to treat progerias and could assist in the redesign of HAART medications to avoid the treatment side effects.
Ste24p is a biomarker for normal aging in humans – as humans get older, this protein works less effectively. So this mapping could provide insight for researchers into the human aging process.